Performance of the BD Phoenix CPO detect assay for detection and classification of carbapenemase-producing organisms
Authors:
Open Access
- 27 November 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 40 (5) , 979-985
Abstract
Increasing worldwide, prevalence of carbapenem-resistant gram-negative bacteria demands urgent a need for rapid detection and accurate identification of carbapenemases. The BD Phoenix CPO detect (PCD) assay possesses an in-built capacity for parallel susceptibility testing and detection of carbapenemases. Here, the ability of the assay to detect and classify carbapenemase production was tested in a collection of carbapenem-resistant Enterobacterales and non-fermentative gram-negative rods. The ability of the PCD assay to detect and classify carbapenemases was investigated in a collection of 194 clinical, carbapenem-resistant isolates (Enterobacterales [n = 65]; non-fermentative gram-negative rods [n = 129]). AST results were compared to MICS determined by gradient diffusion to determine accuracy of the PCD assay. The accuracy of the PCD assay to detect carbapenemases was compared to the results of molecular isolate characterization using a LDT multiplex carbapenemase PCR assay. All 194 isolates classified as carbapenem-resistant by reference susceptibility testing were also classified correctly as CRO by the PCD assay. Performance analysis of the PCD assay to detect carbapenemase production revealed an overall sensitivity of 98.29% and specificity of 17.95% for the detection of carbapenemase production. For the classification of carbapenemases classes A, B, and D, the PCD correctly classified 79.17% Enterobacterales and 67.16% non-fermentative gram-negative rods. The PCD assay is a reliable tool for the detection of carbapenem resistance and allows for parallel analysis of carbapenemase production. However, while sensitivity is high, low specificity in carbapenemase detection and erroneous classification demands mandatory confirmation by alternative methods, especially in non-fermentative gram-negative bacteria.Keywords
Funding Information
- Universitätsklinikum Hamburg-Eppendorf (UKE)
This publication has 37 references indexed in Scilit:
- Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitalsInternational Journal of Medical Microbiology, 2016
- Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in LondonJournal of Infection Prevention, 2015
- The Carbapenem Inactivation Method (CIM), a Simple and Low-Cost Alternative for the Carba NP Test to Assess Phenotypic Carbapenemase Activity in Gram-Negative RodsPLOS ONE, 2015
- Screening Rectal Swabs for Carbapenemase GenesJournal of Clinical Microbiology, 2014
- Rapid detection of carbapenemase genes by multiplex real-time PCRJournal of Antimicrobial Chemotherapy, 2012
- Multiresistant Gram-negative infections: a global perspectiveCurrent Opinion in Infectious Diseases, 2010
- Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase IssuesJournal of Clinical Microbiology, 2010
- Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.International Journal of Antimicrobial Agents, 2006
- Revised Ambler classification of β-lactamasesJournal of Antimicrobial Chemotherapy, 2005
- The structure of β-lactamasesPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980